FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Atropine Sulfate Injection
Status: Currently in Shortage
»Date first posted: No date available
»Therapeutic Categories: Anesthesia; Neurology; Pediatric

Expand all

Accord Healthcare Inc. (Reverified 04/06/2022)

Company Contact Information:
866-941-7875, option 2

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.4 mg/mL, 1 mL single dose vial, pack of 25 (NDC 16729-525-08) Available
0.4 mg/mL, 20 mL multi-dose vial, pack of 10 (NDC 16729-512-43) Available
1 mg/mL, 1 mL single dose vial, pack of 25 (NDC 16729-526-08) Available
0.05 mg/mL, 5 mL prefilled syringe, pack of 10 (NDC 16729-483-03) Available
0.1 mg/mL, 10 mL prefilled syringe, pack of 10 (NDC 16729-484-45) Available
0.1 mg/mL, 5 mL prefilled syringe, pack of 10 (NDC 16729-484-90) Available

American Regent/Luitpold (Revised 04/06/2022)

Company Contact Information:
800-645-1706

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-1010-25) Available
0.4 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-0401-25) Available

Amphastar Pharmaceuticals, Inc./IMS (Reverified 05/06/2022)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.1 mg/mL; 10 mL Luer-Jet Prefilled Syringe (NDC 76329-3340-1) Available

Fresenius Kabi USA, LLC (Reverified 05/04/2022)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
8 mg per 20 mL (0.4 mg per mL); MDV; (NDC 63323-580-20) Available

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 04/08/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.4 mg/mL, 20 mL vial (NDC 0641-6006-10) Inventory is currently available. Additional lots are scheduled for manufacturing and will be available in the May 2022 timeframe. Product will be made available as it is released. Demand increase for the drug

Hospira, Inc. (Revised 05/10/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg/10 mL (0.1 mg/mL); Ansyr Plastic Syringe (NDC 0409-1630-10) Next Delivery: June 2022; Estimated Recovery: July 2022

Pfizer Customer Letter dated March 4, 2022.

Demand increase for the drug
0.25 mg/5 mL (0.05 mg/mL); Ansyr Plastic Syringe (NDC 0409-9630-05) Next Delivery and Estimated Recovery: May 2022

Pfizer Customer Letter dated March 4, 2022.

Demand increase for the drug
0.5 mg/5 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4910-34) Available

Pfizer Customer Letter dated March 4, 2022.

Other
1 mg/10 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4911-34, pack of 10; NDC 0409-4911-11, individual) Available

Pfizer Customer Letter dated March 4, 2022.

Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English